What is Hualan Biological Engineering Inc.'s (002007.SZ) StockRank?

MoatMap's StockRank for Hualan Biological Engineering Inc. (002007.SZ) is 78/100, with a Buy signal. This is a composite score combining Quality (69), Value (42), and Momentum (54) factor ranks across MoatMap's 19,000+ stock universe.

Does Hualan Biological Engineering Inc. have an economic moat?

Hualan Biological Engineering Inc. (002007.SZ) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Hualan Biological Engineering Inc. a buy, hold, or sell?

MoatMap's current signal for Hualan Biological Engineering Inc. (002007.SZ) is Buy, based on a StockRank of 78/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Hualan Biological Engineering Inc. in?

Hualan Biological Engineering Inc. (002007.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002007.SZ

BUYREMOVE

Hualan Biological Engineering Inc. · Healthcare · China · $3.7B · Avg Vol: $20M/d

StockRank

P/E (TTM)

27.9x

ROE

6.6%

D/E

0.0x

Dividend %

7.7%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Hualan Biological Engineering produces blood products and vaccines. While it has decent quality metrics (69), it operates in a highly regulated domestic Chinese market subject to unpredictable government pricing interventions and plasma collection volume constraints.

COMPANY DESCRIPTION

Hualan Biological Engineering Inc. is a leading biopharmaceutical company in China, specializing in plasma-derived products and influenza vaccines. The company operates a vast network of plasma plasmapheresis stations, securing a stable raw material supply that serves as a high barrier to entry. Its competitive moat is reinforced by its dominant market share in domestic human albumin and IVIG markets, alongside its state-of-the-art vaccine manufacturing capabilities.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	668M	789M	647M	679M	0.6%
EPS	0.09	0.12	0.09	0.08	-4.4%
Shares	1.8B	1.8B	1.8B	1.8B	+0.2%
Debt	164M	149M	134M	67M	-25.7%
Equity	1.5B	1.7B	1.8B	1.7B	3.4%
Op CF	141M	199M	157M	130M	-2.8%
Inv CF	-362M	-148M	13M	79M	—
Fin CF	283M	-67M	-115M	-295M	—

PRICE (1M)-10.6%

SMA 50SMA 200

$1.91

RSI (14)

48.8

52W High

$2.54

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

8.8%69.7

ROE

6.6%61.4

GP/Assets

16.3%37.8

Op. Margin

33.8%94.4

FCF/Assets

2.2%58.2

Piotroski

—55.8

Int. Cover

50.0x91.4

D/E Ratio

0.00x98.2

Current Ratio

6.57x78.6

Value

P/E (TTM)

27.9x40.2

EV/EBITDA

17.3x23.0

P/FCF

510.8x15.2

P/B

2.0x54.7

P/S

5.3x38.9

Div Yield

7.7%97.5

Momentum

52W High %

75%65.7

RS 6M

-21%54.8

SMA 50/200

0.93x42.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+138%80.4

Q Growth

-26%20.3

FUNDAMENTALS

Market Cap

$3.7B

P/E (Forward)

11.7x

Gross Margin

55.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002007.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002007.SZ	Hualan Biological Engineering Inc.(you)	$3.7B	78	BUY
688336.SS	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd	$5.9B	79	BUY
002821.SZ	Asymchem Laboratories (Tianjin) Co., Ltd.	$6.3B	80	BUY
300009.SZ	Anhui Anke Biotechnology (Group) Co., Ltd.	$2.1B	86	STRONG BUY
688278.SS	Xiamen Amoytop Biotech Co., Ltd.	$3.4B	58	HOLD
3759.HK	Pharmaron Beijing Co., Ltd.	$4.1B	59	HOLD
2315.HK	Biocytogen Pharmaceuticals (Beijing) Co., Ltd.	$2.8B	61	HOLD
688578.SS	Shanghai Allist Pharmaceuticals Co., Ltd.	$6.0B	94	STRONG BUY
1530.HK	3SBio Inc.	$5.9B	96	STRONG BUY
000990.SZ	Chengzhi Co., Ltd.	$1.7B	64	HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

Hualan Biological Engineering Inc. (002007.SZ) — Stock Score Summary

Hualan Biological Engineering Inc. (002007.SZ) has a MoatMap StockRank of 78/100 based on Quality (69/100), Value (42/100), and Momentum (54/100) factor scores. The current signal is BUY. Hualan Biological Engineering produces blood products and vaccines. While it has decent quality metrics (69), it operates in a highly regulated domestic Chinese market subject to unpredictable government pricing interventions and plasma collection volume constraints.

Key Financial Metrics

Price	$1.91
Market Cap	$3.7B
P/E (TTM)	27.87
P/E (Forward)	11.70
Price/Book	2.04
Return on Equity	6.6%
Return on Invested Capital	8.8%
Debt/Equity	0.07
Gross Margin	55.2%
Operating Margin	33.8%
Revenue Growth	-12.2%
Dividend Yield	7.7%
Free Cash Flow	$7M

Hualan Biological Engineering Inc. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Hualan Biological Engineering Inc.’s (002007.SZ) StockRank?: MoatMap’s StockRank for Hualan Biological Engineering Inc. (002007.SZ) is 78/100, with a Buy signal. It is a composite of Quality (69), Value (42), and Momentum (54) factor ranks across MoatMap’s 19,000+ stock universe.
Does Hualan Biological Engineering Inc. have an economic moat?: Hualan Biological Engineering Inc. (002007.SZ) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hualan Biological Engineering Inc. a buy, hold, or sell?: MoatMap’s current signal for Hualan Biological Engineering Inc. (002007.SZ) is Buy, based on a StockRank of 78/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hualan Biological Engineering Inc. in?: Hualan Biological Engineering Inc. (002007.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).